Mesoblast

What indicators would you like to setup a trade for?

Candlestick Daily volume index Bar reversal Edit

Trade setup

Position Order Entry Exit Stop Loss Risk Return Expectancy
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

Company

Indicator

Code Company Date Close Change Indicator Value Signal

Trading Performance

Stochastic Oscillator

Score

0.95

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 36 8.9 0.42% 0.71% 9.6% -3.2% 77.8%
SHORT 36 13.1 0.42% 0.65% 11.5% -4.6% 66.4%

Summary

Technical Analysis


In technical analysis of securities trading the stochastic oscillator is a momentum indicator that uses support and resistance levels. Dr George Lane developed this indicator in the late 1950s. The term stochastic refers to the point of a current price in relation to its price range over a period of time. This method attempts to predict price turning points by comparing the closing price of a security to its price range.

Calculation: Stochastic Oscillator:
1) %K = (Current Close - Lowest Low)/(Highest High - Lowest Low) * 100;
2) %D = 3-day SMA of %K Lowest Low = lowest low for the look-back period Highest High = highest high for the look-back period %K is multiplied by 100 to move the decimal point two places;


PROFILE: Mesoblast (MSB.AX)


Stock Exchange: ASX
Company: Mesoblast
Ticker Codes: | MSB.AX | ASX:MSB |

About Mesoblast (ASX:MSB):

Mesoblast Limited develops cell-based medicines. The company has leveraged its proprietary technology platform based on mesenchymal lineage adult stem cells to establish a portfolio of late-stage product candidates. Its allogeneic cell product candidates target advanced stages of diseases with high and unmet medical needs, including cardiovascular conditions, immunologic and inflammatory conditions, orthopedic disorders, and oncology and hematology conditions. The company's products under the Phase III clinical trials include MPC-150-IM for chronic and end-stage heart failure; MPC-06-ID for chronic low back pain; and MSC-100-IV for acute graft versus host disease in children. It is also developing MPC-300-IV that is in Phase II clinical trials for the treatment of biologic refractory rheumatoid arthritis, and diabetic kidney diseases and type 2 diabetes. The company has a collaboration agreement with JCR Pharmaceuticals Co., Ltd. It has operations in the United States, Australia, Singapore, and Switzerland. Mesoblast Limited was founded in 2004 and is headquartered in Melbourne, Australia.

Top 10:

Stochastic Oscillator

Download
Company Close Change(%) Volume Value Signal
BSE BSE 0.24 6.8 118,988 39.5 NEUTRAL
CGS Cogstate 0.37 5.7 22,000 70.5 NEUTRAL
IPD Impedimed 0.2 5.3 1,022,395 36.4 NEUTRAL
CDD Cardno 0.47 4.4 241,998 30.5 NEUTRAL
PME Pro Medicus 26.25 4.3 385,232 71.1 NEUTRAL
BOC Bougainville Copper 0.13 4 66,042 69.6 NEUTRAL
AAC Australian Agricultural 1.05 4 1,597,445 69.6 NEUTRAL
PPC Peet & Company 1.28 3.7 84,175 53.3 NEUTRAL
LVH Livehire 0.29 3.6 140,281 51.7 NEUTRAL
WEB Webjet 12.88 3.5 3,588,652 25 NEUTRAL